chr18-59480158-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133459.4(CCBE1):​c.265+28G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.616 in 1,389,622 control chromosomes in the GnomAD database, including 266,523 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 33110 hom., cov: 34)
Exomes 𝑓: 0.61 ( 233413 hom. )

Consequence

CCBE1
NM_133459.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.968
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 18-59480158-C-G is Benign according to our data. Variant chr18-59480158-C-G is described in ClinVar as [Benign]. Clinvar id is 262351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.824 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCBE1NM_133459.4 linkc.265+28G>C intron_variant Intron 3 of 10 ENST00000439986.9 NP_597716.1 Q6UXH8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCBE1ENST00000439986.9 linkc.265+28G>C intron_variant Intron 3 of 10 1 NM_133459.4 ENSP00000404464.2 Q6UXH8-1

Frequencies

GnomAD3 genomes
AF:
0.657
AC:
99782
AN:
151942
Hom.:
33095
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.728
Gnomad AMI
AF:
0.769
Gnomad AMR
AF:
0.691
Gnomad ASJ
AF:
0.550
Gnomad EAS
AF:
0.844
Gnomad SAS
AF:
0.604
Gnomad FIN
AF:
0.586
Gnomad MID
AF:
0.601
Gnomad NFE
AF:
0.610
Gnomad OTH
AF:
0.670
GnomAD3 exomes
AF:
0.645
AC:
158385
AN:
245694
Hom.:
52008
AF XY:
0.635
AC XY:
84439
AN XY:
132898
show subpopulations
Gnomad AFR exome
AF:
0.729
Gnomad AMR exome
AF:
0.734
Gnomad ASJ exome
AF:
0.569
Gnomad EAS exome
AF:
0.842
Gnomad SAS exome
AF:
0.589
Gnomad FIN exome
AF:
0.591
Gnomad NFE exome
AF:
0.606
Gnomad OTH exome
AF:
0.623
GnomAD4 exome
AF:
0.611
AC:
755824
AN:
1237562
Hom.:
233413
Cov.:
18
AF XY:
0.609
AC XY:
382182
AN XY:
627208
show subpopulations
Gnomad4 AFR exome
AF:
0.719
Gnomad4 AMR exome
AF:
0.733
Gnomad4 ASJ exome
AF:
0.561
Gnomad4 EAS exome
AF:
0.831
Gnomad4 SAS exome
AF:
0.587
Gnomad4 FIN exome
AF:
0.593
Gnomad4 NFE exome
AF:
0.596
Gnomad4 OTH exome
AF:
0.621
GnomAD4 genome
AF:
0.657
AC:
99840
AN:
152060
Hom.:
33110
Cov.:
34
AF XY:
0.655
AC XY:
48698
AN XY:
74310
show subpopulations
Gnomad4 AFR
AF:
0.728
Gnomad4 AMR
AF:
0.691
Gnomad4 ASJ
AF:
0.550
Gnomad4 EAS
AF:
0.844
Gnomad4 SAS
AF:
0.602
Gnomad4 FIN
AF:
0.586
Gnomad4 NFE
AF:
0.610
Gnomad4 OTH
AF:
0.662
Alfa
AF:
0.617
Hom.:
5269
Bravo
AF:
0.674
Asia WGS
AF:
0.708
AC:
2458
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 86% of patients studied by a panel of primary immunodeficiencies. Number of patients: 82. Only high quality variants are reported. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 10, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.43
DANN
Benign
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1790508; hg19: chr18-57147390; COSMIC: COSV67950975; API